A multicenter experience with the Talent endovascular graft for the treatment of abdominal aortic aneurysms

Abstract

These midterm findings show a high degree of technical and procedural success achieved in a patient population with extensive comorbid medical illnesses with low perioperative morbidity and mortality rates. Further follow-up study will be necessary to determine the effectiveness of the Talent endograft for the long-term treatment of AAA.

Five-year results for the Talent enhanced Low Profile System abdominal stent graft pivotal trial including early and long-term safety and efficacy

“…Treatment using EVAR has resulted in low rates of aneurysm expansion of 8.7% after 6 months of followup 15 and demonstrable sac shrinkage of 52% Ϯ 9.7% at 12 months. 23 Freedom from endoleak has been reported to be All-cause mortality 2 (1.5) Myocardial infarction 0 (0) Renal failure 0 (0) Respiratory failure 1 (0.7) Paraplegia 0 (0) Stroke 0 (0) Bowel ischemia 0 (0) Procedural blood loss Ն1000 mL 4 (2.9) Total 6 (4.4) a Major adverse events related to the delivery system, defined as for the enhanced Low Profile System group, by the presence of any of the listed events, observed Յ30 days after the procedure.…”

“…13,14 Previous reports evaluating the safety of the Talent stent graft demonstrate satisfactory results with low complication rates. [15][16][17] The initial reports of the pivotal trial indicated a deployment success rate of 98.7% and device or procedure related complications of only 3.7%. 9,18 Survival rates of 92.7% to 95.4% at 1 year and 50% to 80.3% at 5 years have been reported.…”

Stent graft treatment for abdominal aortic aneurysm repair: recent developments in therapy

“…A recent report has been prepared summarizing the results of an FDA-sponsored investigational device exemption trial for high-risk patients [19]. In the US trial, all patients either had significant comorbid medical conditions or had a hostile abdomen.…”

Percutaneous Interventions in Aortic Disease

“…This was significantly higher (14.1%) in the open exposure group. 6 Many studies support a reduction in groin complications, including wound infection, seroma, hematoma, lymph leak, and pseudoaneurysm, 34,44 when the percutaneous approach is used for endovascular repair of aneurysms. One such study quoted a >30% incidence of groin complications with EVAR compared with a <10% complication rate with PEVAR.…”